Australia markets close in 36 minutes

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.41-0.34 (-1.32%)
At close: 04:00PM EDT
25.41 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 376.79M
Enterprise value 336.64M
Trailing P/E 43.00
Forward P/E 23.53
PEG ratio (5-yr expected) 2.35
Price/sales (ttm)2.20
Price/book (mrq)1.81
Enterprise value/revenue 1.99
Enterprise value/EBITDA -72.65

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3-5.47%
S&P500 52-week change 327.84%
52-week high 328.67
52-week low 316.54
50-day moving average 325.84
200-day moving average 322.31

Share statistics

Avg vol (3-month) 378.28k
Avg vol (10-day) 366.8k
Shares outstanding 514.83M
Implied shares outstanding 614.83M
Float 810.93M
% held by insiders 12.97%
% held by institutions 191.40%
Shares short (30 Apr 2024) 4808.11k
Short ratio (30 Apr 2024) 414.2
Short % of float (30 Apr 2024) 47.53%
Short % of shares outstanding (30 Apr 2024) 45.45%
Shares short (prior month 28 Mar 2024) 4770.4k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -45.39%
Operating margin (ttm)-23.67%

Management effectiveness

Return on assets (ttm)-1.81%
Return on equity (ttm)-31.61%

Income statement

Revenue (ttm)169.26M
Revenue per share (ttm)11.54
Quarterly revenue growth (yoy)6.90%
Gross profit (ttm)N/A
EBITDA 3.99M
Net income avi to common (ttm)-76.83M
Diluted EPS (ttm)-5.24
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)68.63M
Total cash per share (mrq)4.63
Total debt (mrq)28.47M
Total debt/equity (mrq)13.65%
Current ratio (mrq)5.59
Book value per share (mrq)14.07

Cash flow statement

Operating cash flow (ttm)1.7M
Levered free cash flow (ttm)6.54M